Vildagliptin 50mgTablet
Diabetes & Metabolic

Vildagliptin 50mg

Vildagliptin

Selective DPP-4 inhibitor with potent enzyme inhibition that improves glycemic control through enhanced incretin-mediated insulin secretion and suppressed post-meal glucagon release. Widely prescribed as a fixed-dose combination with metformin (Galvusmet) offering convenient dual-mechanism therapy without weight gain.

Strengths

50mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Vildagliptin 50mg
Dosage Form
Tablet
Available Strengths
50mg
Packing
10 tablets/strip
Route of Administration
Oral, with or without food
Dosage
50mg twice daily (with metformin or thiazolidinedione) or 50mg once daily (with sulfonylurea); max 100mg/day
Indications
Type 2 diabetes mellitus in combination with other antidiabetic agents when diet, exercise, and monotherapy provide insufficient glycemic control
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 25°C, protected from moisture
Shelf Life
36 months
Side Effects
Nasopharyngitis, dizziness, headache, peripheral edema, hypoglycemia (when combined with sulfonylurea); liver enzyme elevations
Precautions
Liver function monitoring required; dose not recommended in severe renal impairment; pancreatitis risk; avoid in hepatic impairment

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Glimepiride 2mgTablet

Glimepiride 2mg

Glimepiride

Third-generation sulfonylurea that stimulates pancreatic beta-cell insulin secretion via selective SUR1 receptor binding, offering a lower hypoglycemia risk compared to earlier sulfonylureas due to glucose-dependent activity. The most cost-effective oral antidiabetic agent in its class and a cornerstone of type 2 diabetes management in emerging markets.

1mg / 2mg / 3mg / 4mg
Sitagliptin 100mgTablet

Sitagliptin 100mg

Sitagliptin Phosphate

First-in-class DPP-4 inhibitor that amplifies incretin-mediated glucose-dependent insulin secretion while suppressing glucagon, offering glycemic control without weight gain or intrinsic hypoglycemia risk. Once-daily dosing, renal dose adjustment flexibility, and a decade-long cardiovascular safety record make it a globally preferred add-on antidiabetic.

25mg / 50mg / 100mg
Pioglitazone 30mgTablet

Pioglitazone 30mg

Pioglitazone Hydrochloride

PPAR-gamma agonist thiazolidinedione that improves insulin sensitivity in peripheral tissues — muscle, fat, and liver — and favorably modifies lipid profiles by increasing HDL and reducing triglycerides. Uniquely addresses the underlying insulin resistance pathophysiology of type 2 diabetes and is widely used in combination regimens across Asia and Africa.

15mg / 30mg / 45mg

Need bulk pricing for Vildagliptin 50mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote